Table 1.
Patient and lesion characteristics
| Characteristics | Transoral group (N = 62) | Transcutaneous group (N = 50) | P value* |
|---|---|---|---|
| Age (mean ± standard), yearsa | 60.7 ± 11.7 | 59.8 ± 11.9 | 0.69 |
| Male/female | 41/21 | 33/17 | 0.98 |
| Size of tumor (mean ± standard), mma | 30.0 ± 12.9 | 30.9 ± 13.2 | 0.71 |
| Bleeding parameters | |||
| Platelet, 109/La | 192.8 ± 51 | 189.7 ± 49 | 0.76 |
| PT, sa | 10.7 ± 0.8 | 10.6 ± 0.7 | 0.26 |
| INRa | 0.97 ± 0.1 | 0.97 ± 0.07 | 0.84 |
| aPTT, sa | 27.9 ± 3.7 | 27.7 ± 2.9 | 0.33 |
| Tumor location | |||
| Oral tongue | 15 | 13 | 0.83 |
| Floor of the mouth | 11 | 11 | 0.57 |
| Gingiva | 5 | 4 | 0.53 |
| Hard palate | 6 | 0 | 0.03 |
| Base of the tongue | 15 | 14 | 0.65 |
| Parapharyngeal space | 5 | 4 | 0.99 |
| Tonsil | 5 | 4 | 0.99 |
PT prothrombin time, INR international normalized ratio, aPTT activated partial thromboplastin time
Unless otherwise noted, data are numbers of patients or lesions
aData are mean ± standard deviations
*Independent sample T-test was used for comparisons of quantitative variables. Pearson Chi-square test and Fisher’s exact test were applied for comparisons of categorical variables